These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31648878)

  • 21. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial efficacy evaluation and mechanism probe of small lysine chalcone peptide mimics.
    Shen BY; Wang MM; Xu SM; Gao C; Wang M; Li S; Ampomah-Wireko M; Chen SC; Yan DC; Qin S; Zhang E
    Eur J Med Chem; 2022 Dec; 244():114885. PubMed ID: 36334451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
    Socha AM; LaPlante KL; Rowley DC
    Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
    Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
    Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
    Eliopoulos GM
    J Infect; 2009 Sep; 59 Suppl 1():S17-24. PubMed ID: 19766885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
    David MZ; Dryden M; Gottlieb T; Tattevin P; Gould IM
    Int J Antimicrob Agents; 2017 Sep; 50(3):303-307. PubMed ID: 28666751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic activity of the lantibiotic MU1140.
    Ghobrial OG; Derendorf H; Hillman JD
    Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013.
    Karlowsky JA; Walkty AJ; Baxter MR; Adam HJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):311-5. PubMed ID: 25294303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD; Jones DG; Sánchez Bruni SF
    Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compound.
    Keating TA; Newman JV; Olivier NB; Otterson LG; Andrews B; Boriack-Sjodin PA; Breen JN; Doig P; Dumas J; Gangl E; Green OM; Guler SY; Hentemann MF; Joseph-McCarthy D; Kawatkar S; Kutschke A; Loch JT; McKenzie AR; Pradeepan S; Prasad S; Martínez-Botella G
    ACS Chem Biol; 2012 Nov; 7(11):1866-72. PubMed ID: 22908966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
    Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
    Moreira CS; Silva AC; Novais JS; Sá Figueiredo AM; Ferreira VF; da Rocha DR; Castro HC
    J Appl Microbiol; 2017 Mar; 122(3):651-662. PubMed ID: 27930849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
    Severina E; Severin A; Tomasz A
    J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance.
    Valle DL; Cabrera EC; Puzon JJ; Rivera WL
    PLoS One; 2016; 11(1):e0146349. PubMed ID: 26741962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
    Barbour A; Schmidt S; Rand KH; Derendorf H
    Int J Antimicrob Agents; 2009 Jul; 34(1):1-7. PubMed ID: 19261449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.